← All organizations

Highest phase reached
Phase 3
First clinical trial
Jun 8, 2017First marketed drug
Jul 21, 2023First NDA
Jul 21, 2023Last known activity
Dec 31, 2025
Timeline
2010s
- Jun 1, 2013
Verrica Pharmaceuticals Inc.— Founded
2020s
- Jul 21, 2023
cantharidin— Marketing Organization
- Jul 21, 2023
cantharidin— NDA Organization
- Jul 21, 2023
cantharidin— NDA Secondary Org
Drugs by trial phase (2 distinct, 7 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Marketed drugs (1)
Recent trials (8)
- NCT07246590Lead sponsorPhase 3Dec 31, 2025
- NCT05188729Lead sponsorPhase 2Feb 1, 2022
- NCT03981822Lead sponsorPhase 2Jun 27, 2019
- NCT03487549Lead sponsorPhase 2Mar 27, 2018
- NCT03377790Lead sponsorPhase 3Mar 21, 2018
- NCT03377803Lead sponsorPhase 3Feb 14, 2018
- NCT03186378Lead sponsorPhase 2Jun 8, 2017
- NCT03186378Study directorPhase 2Jun 8, 2017
Details
- Founded
- West Chester, PA, US Jun 1, 2013
- First NDA
- Jul 21, 2023
- Last known activity
- Dec 31, 2025